- Home
- HLX vs CRMD Comparison
HLX vs CRMD Comparison
Compare HLX & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HLX
- CRMD
- Stock Information
- Founded
- HLX 1979
- CRMD 2006
- Country
- HLX United States
- CRMD United States
- Employees
- HLX N/A
- CRMD N/A
- Industry
- HLX Oilfield Services/Equipment
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- HLX Energy
- CRMD Health Care
- Exchange
- HLX Nasdaq
- CRMD Nasdaq
- Market Cap
- HLX 928.9M
- CRMD 871.9M
- IPO Year
- HLX 1997
- CRMD 2010
- Fundamental
- Price
- HLX $6.73
- CRMD $11.14
- Analyst Decision
- HLX Strong Buy
- CRMD Strong Buy
- Analyst Count
- HLX 2
- CRMD 8
- Target Price
- HLX $10.50
- CRMD $17.75
- AVG Volume (30 Days)
- HLX 1.5M
- CRMD 2.4M
- Earning Date
- HLX 10-22-2025
- CRMD 11-10-2025
- Dividend Yield
- HLX N/A
- CRMD N/A
- EPS Growth
- HLX 497.36
- CRMD N/A
- EPS
- HLX 0.28
- CRMD 0.79
- Revenue
- HLX $1,312,445,000.00
- CRMD $121,484,498.00
- Revenue This Year
- HLX N/A
- CRMD $480.51
- Revenue Next Year
- HLX $13.14
- CRMD $59.81
- P/E Ratio
- HLX $23.82
- CRMD $14.08
- Revenue Growth
- HLX N/A
- CRMD 14970.29
- 52 Week Low
- HLX $5.52
- CRMD $5.60
- 52 Week High
- HLX $11.48
- CRMD $17.43
- Technical
- Relative Strength Index (RSI)
- HLX 55.28
- CRMD 48.18
- Support Level
- HLX $6.14
- CRMD $10.92
- Resistance Level
- HLX $7.97
- CRMD $11.57
- Average True Range (ATR)
- HLX 0.32
- CRMD 0.58
- MACD
- HLX 0.04
- CRMD 0.09
- Stochastic Oscillator
- HLX 32.64
- CRMD 47.16
About HLX Helix Energy Solutions Group Inc.
Helix Energy Solutions Group Inc is an offshore energy services company. It provides specialty services to the offshore energy industry, with an emphasis on well intervention and robotics operations. Helix provides services in deep water in the Gulf of Mexico, Brazil, the North Sea, Asia Pacific and West Africa regions. It has four segments: Well Intervention, Robotics, Shallow Water Abandonment and Production Facilities. the Well Intervention segment includes vessels and equipment used to perform well intervention services in the Gulf of Mexico, the North Sea and Brazil. It derives the majority of its revenue from the U.S.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.